Literature DB >> 1150427

Ergotamine headache.

P G Andersson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1150427     DOI: 10.1111/j.1526-4610.1975.hed1502118.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  8 in total

1.  Analgesic-induced chronic headache: long-term results of withdrawal therapy.

Authors:  H C Diener; J Dichgans; E Scholz; S Geiselhart; W D Gerber; A Bille
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

Review 2.  Analgesic rebound headache. How great is the problem and what can be done?

Authors:  S D Silberstein; W B Young
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

3.  Low-dose propranolol therapy for aborting migraine.

Authors:  H J Featherstone
Journal:  West J Med       Date:  1983-03

4.  Management of chronic headache.

Authors:  R Smith
Journal:  Can Fam Physician       Date:  1989-09       Impact factor: 3.275

Review 5.  Clinical pharmacokinetics of ergotamine in migraine and cluster headache.

Authors:  V L Perrin
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

6.  Chronic Daily Headache.

Authors:  James R. Couch
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

7.  The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HT1C receptor agonists in piglet choroid plexus.

Authors:  A M Brown; T L Patch; A J Kaumann
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

Review 8.  The long-term prognosis of tension-type headache.

Authors:  James R Couch
Journal:  Curr Pain Headache Rep       Date:  2005-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.